Refractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamab

Clinical trial NCT07061080 · RECRUITING

Trial details

NCT number: NCT07061080
Sponsor: Grupo Espanol de Tumores Neuroendocrinos
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Neuroendocrine Carcinomas of The Digestive System Advanced Neuroendocrine Carcinomas Unknown Primary Origin

Start date: 2025-12-18
Primary completion: 2028-12-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.